Skin Cell Regeneration Efficacy of Cosmetic Product

Inclusion criteria

• Written informed consent to participate in the study
• Willingness to actively participate in the study and to come to the scheduled visits
• Female and/or male
• From 18 to 65 years of age
• Healthy skin in the test area
• Uniform skin color in the test area
• Fitzpatrick I-III
• Able to read and follow directions as outlined in the protocol

Exclusion criteria

• Female subjects: Pregnancy or lactation
• Drug addicts, alcoholics
• AIDS, HIV-positive or infectious hepatitis
• Conditions which exclude a participation or might influence the test reaction/evaluation
• Participation or being in the waiting period after participation in cosmetic and/or pharmaceutical studies pertaining to the test area
• Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years
• Insulin-dependent diabetes mellitus (type 1 and 2)
• Documented allergies to cosmetic products and/or ingredients,
• Documented allergies to plaster systems or tape adhesives
• Active skin disease at the test area like acute dermatitis, that requires actual topical medication on the test area and/or systemic drug treatment according to a physician
• Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, etc. at the test area that could influence the investigation
• All kinds of beard (except a moustache) during the whole study
• Any topical medication at the test area within the last 3 days prior to the start of the study and throughout the entire course of the study
• Topical medication with anti-inflammatories, antihistamines within 1 week prior to the start of the study
• Topical medication with Immuno-suppressive medication within 2 weeks prior to the start of the study
• Systemic (oral) medication with Antibiotic (except penicillin) or anti-inflammatory steroids within 4 weeks prior to the start of the study and throughout the entire course of the study
• Systemic (oral) medication with anti-inflammatory non-steroids within 2 weeks prior to the start of the study and throughout the entire course of the study
• Phototherapy within 4 weeks prior to the start of the study and throughout the entire course of the study
• Systemic (oral) medication with retinoids within 6 months prior to the start of the study and throughout the entire course of the study